Cadrenal Therapeutics Inc. Common Stock
CVKD | NASDAQ
$1.09
$0 (0.00%)
Sep 22, 2026, 2:33 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 956 | 956 | 5.92K | 5.92K | 5.52K | 5.52K | n/a | n/a | n/a | 597 | 597 | 1.36K | 1.36K | 760 | 760 | n/a | n/a | n/a |
Gross Profit | -956 | -956 | -5.92K | -5.92K | -5.52K | -5.52K | n/a | n/a | n/a | -597 | -597 | -1.36K | -1.36K | -760 | -760 | n/a | n/a | n/a |
Operating Income | -11.65M | -12.05M | -13.46M | -14.67M | -14.4M | -13.13M | -10.96M | -7.95M | -6.63M | -5.19M | -7.63M | -7.44M | -7.28M | -6.73M | -2.7M | -1.63M | -652.87K | -170.52K |
Interest Income | 92.05K | 159.06K | 223.81K | 288.86K | 292.89K | 299.52K | 309.25K | 337.86K | 391.88K | 341.42K | 249.09K | 129.32K | 23.18K | 3 | 3 | 3 | n/a | n/a |
Pretax Income | -8.22M | -11.89M | -13.24M | -14.39M | -14.11M | -12.83M | -10.65M | -7.61M | -6.24M | -4.85M | -8.36M | -12.22M | -12.21M | -11.71M | -6.71M | -1.7M | -678.79K | -176.65K |
Net Income | -8.22M | -11.89M | -13.24M | -14.39M | -14.11M | -12.83M | -10.65M | -7.61M | -6.24M | -4.85M | -8.36M | -12.22M | -12.21M | -11.71M | -6.71M | -1.7M | -678.79K | -176.65K |
Selling & General & Admin | 8.82M | 8.84M | 9.35M | 9.7M | 9.33M | 7.88M | 6.75M | 4.92M | 4.14M | 3.71M | 3.55M | 3.61M | 3.62M | 3.12M | 2.31M | 1.35M | 432.77K | 152.66K |
Research & Development | 2.83M | 3.2M | 4.1M | 4.97M | 5.07M | 5.24M | 4.21M | 3.03M | 2.49M | 1.48M | 4.08M | 3.84M | 3.65M | 3.61M | 392.86K | 276.48K | 220.1K | 17.86K |
Other Expenses | 2.02K | 1.91K | 1.36K | 1.21K | 1.22K | 1.28K | 1.88K | 2.07K | 2.26K | 2.39K | 1.98K | 878 | 787 | 190 | 0 | 506 | 0 | n/a |
Operating Expenses | 11.65M | 12.05M | 13.46M | 14.67M | 14.4M | 13.13M | 10.96M | 7.95M | 6.63M | 5.19M | 7.63M | 7.44M | 7.27M | 6.73M | 2.7M | 1.63M | 652.87K | 170.52K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.1K | 72.84K | 104.85K | 119.62K | 107.11K | 51.37K | 19.36K | 4.59K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -389.84K | -389.84K | -389.84K | -389.84K | n/a | n/a | n/a |
Cost & Expenses | 8.31M | 12.05M | 13.46M | 14.67M | 14.4M | 13.13M | 10.96M | 7.95M | 6.63M | 5.19M | 7.63M | 7.44M | 7.28M | 6.73M | 2.7M | 1.63M | 652.87K | 170.52K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.91M | 2.41M | 1.99M | 2.04M | 1.96M | 1.84M | 1.53M | 1.1M | 1.07M | 1.07M | 868.18K | 868.18K | 781.52K | 781.52K | 775.64K | 11.63M | 11.63M | 11.63M |
Shares Outstanding (Diluted) | 2.91M | 2.41M | 1.99M | 2.04M | 1.96M | 1.84M | 1.53M | 1.1M | 1.07M | 1.07M | 868.18K | 868.18K | 781.52K | 781.52K | 775.64K | 11.63M | 11.63M | 11.63M |
EPS (Basic) | -4.90 | -5.63 | -6.68 | -8.02 | -8.89 | -9.26 | -8.72 | -7.29 | -6.30 | -5.34 | -10.41 | -15.55 | -14.45 | -13.21 | -6.61 | -0.15 | -0.06 | -0.02 |
EPS (Diluted) | -4.90 | -5.63 | -6.68 | -8.02 | -8.89 | -9.26 | -8.72 | -7.29 | -6.30 | -5.34 | -10.41 | -15.55 | -14.45 | -13.21 | -6.61 | -0.15 | -0.06 | -0.02 |
EBITDA | -11.56M | -11.89M | -13.23M | -14.38M | -14.1M | -12.83M | -10.65M | -7.61M | -6.23M | -4.84M | -8.34M | -12.15M | -12.11M | -11.59M | -6.6M | -1.65M | -656.92K | -169.55K |
EBIT | -8.22M | -11.89M | -13.24M | -14.39M | -14.11M | -12.83M | -10.65M | -7.61M | -6.24M | -4.85M | -8.34M | -12.15M | -12.11M | -11.59M | -6.61M | -1.65M | -659.43K | -172.06K |
Depreciation & Amortization | 1.51K | 1.91K | 6.87K | 6.73K | 6.73K | 6.8K | 1.88K | 2.07K | 2.26K | 2.39K | 1.98K | 2.14K | 2.05K | 1.46K | 3.77K | 3.01K | 2.51K | 2.51K |
Add to Watchlist
Select watchlists to add or remove CVKD